Abstract: A multiband antenna comprises a dielectric substrate with a first surface defining an annular ledge and a central recess with a plurality of pockets. A MIMO radiator body is disposed in the central recess having a first surface defining a plurality of lobes which are disposed in respective ones of the plurality of pockets and having a second surface defining an outer rim and a central shelf. A radiator ring is disposed at the annular ledge so that the radiator ring and the outer rim converge along an annular gap therebetween. A plurality of MIMO feed lines provide external connection to respective lobes. The MIMO radiator body and the radiator ring provide a substantially horizontally-directed radiation pattern (e.g., for terrestrial signals). At least one low-profile radiator on the central shelf provides a substantially circularly polarized or vertically-directed radiation pattern for receiving signals radiated from a satellite.
Type:
Grant
Filed:
November 16, 2020
Date of Patent:
December 13, 2022
Assignees:
FORD GLOBAL TECHNOLOGIES, LLC, OHIO STATE INNOVATION FOUNDATION
Inventors:
John F. Locke, Chi-Chih Chen, Jiukun Che
Abstract: An open circuit voltage photodetector comprises a photovoltaic device including a photovoltaic junction, and a transistor. The photovoltaic device is connected to the gate terminal of the transistor to input an open circuit voltage of the photovoltaic device to the gate terminal. An array of such photodetectors and a readout integrated circuit forms an image sensor. In a photodetection method, an open circuit voltage is generated in a photovoltaic device in response to illumination by incident radiation, and the open circuit voltage is applied to a gate terminal of a transistor to modulate a channel current flowing in a channel of the transistor. A readout electronic circuit may be fabricated with an extra transistor, and a photovoltaic device disposed on the readout electronic circuit and electrically connected to apply an open circuit voltage of the photovoltaic device to a gate of the extra transistor.
Abstract: Disclosed herein are compositions and methods that involve using compositions containing one or more of ETV2, FOXC2, FLI1 and a miR-200b inhibitor for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
Type:
Grant
Filed:
December 20, 2017
Date of Patent:
December 6, 2022
Assignee:
Ohio State Innovation Foundation
Inventors:
Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
Abstract: A transition structure includes a metallic portion, a fiber portion including a plurality of tows embedded within the metallic portion and extending out from the metallic portion forming a fabric, and a binding material forming a matrix surrounding the fiber portion embedded within the metallic portion. The fiber portion may be attached to or form part of a composite vehicle component. The transition structure may join a metallic component and a composite component. The transition structure may be manufactured by creating first channels within a layer of a metallic substrate, inserting fiber tows into the first channels, placing a first metallic layer over the metallic substrate and the fiber tows, consolidating the metallic layer to the metallic substrate, and binding the fiber tows within a resin. Prior to binding, additional layers of channels and fiber tows may be consolidated onto the first metallic layer.
Type:
Grant
Filed:
October 13, 2020
Date of Patent:
November 29, 2022
Assignees:
HONDA MOTOR CO., LTD., OHIO STATE INNOVATION FOUNDATION
Inventors:
Ryan Hahnlen, Duane Detwiler, Allen Sheldon, Marcelo Dapino, Mark Bryant Gingerich, Matthew Scheidt, Leon Headings
Abstract: The present disclosure provides novel polypeptide conjugates. The polypeptide conjugates disclosed herein comprise a stapled peptide comprising a peptide and at least one staple which holds the peptide in an ?-helical conformation, and a cyclic cell-penetrating peptide (cCPP) conjugated, directly or indirectly, to the stapled peptide. The present disclosure demonstrates that cCPPs can be used to confer consistent cell-permeability to stapled peptides.
Abstract: Cosmeceutical compositions for and methods of improving the appearance of skin and promoting hair growth are provided. Said compositions comprise at least one ROS-scavenging polymer gel, at least MG53, or a combination thereof. A novel boronate ester-based copolymer forms an aqueous hydrogel exhibiting lower viscosity at cooler temperatures and higher viscosity at higher temperatures is provided.
Type:
Application
Filed:
July 22, 2022
Publication date:
November 24, 2022
Applicant:
OHIO STATE INNOVATION FOUNDATION
Inventors:
Jianjie MA, Jianjun GUAN, Haichang LI, Hong NIU, Ya GUAN, Tao TAN
Abstract: A lateral interband Type II engineered (LITE) detector is provided. LITE detectors use engineered heterostructures to spatially separate electrons and holes into separate layers. The device may have two configurations, a positive intrinsic (PIN) configuration and a BJT (Bipolar junction transistor) configuration. The PIN configuration may have a wide bandgap (WBG) layer that transports the holes above a narrow bandgap (NBG) absorber layer that absorbs the target radiation and transports the electrons. The BJT configuration may have a WBG layer operating as a BJT above an NBG layer. In both configurations, the LITE design uses a Type II staggered offset between the NBG layers and the WBG layers that provides a built-in field for the holes to drift from an absorber region to a transporter region.
Type:
Grant
Filed:
August 6, 2020
Date of Patent:
November 22, 2022
Assignee:
Ohio State Innovation Foundation
Inventors:
Sanjay Krishna, Sri Harsha Kodati, Theodore Ronningen, Seunghyun Lee
Abstract: Provided herein are compositions comprising a biocompatible microsphere, a biofilm-generating probiotic bacterium, a prebiotic, and/or a prebiofilmic. Methods for preparing and formulating the compositions and methods for treating or preventing a disease using the compositions are also provided.
Type:
Grant
Filed:
March 16, 2020
Date of Patent:
November 15, 2022
Assignees:
Research Institute at Nationwide Children's Hospital, Ohio State Innovation Foundation
Inventors:
Steven D. Goodman, Lauren O. Bakaletz, Michael Bailey, Gail Besner
Abstract: Disclosed are methods for performing dynamic nuclear polarization using the polarizing agents described herein. In general, the methods involve (a) providing a frozen sample in a magnetic field, wherein the frozen sample includes a polarizing agent described herein and an analyte with at least one spin half nucleus; (b) polarizing the at least one spin half nucleus of the analyte by irradiating the frozen sample with radiation having a frequency that excites electron spin transitions in the polarizing agent; (c) optionally melting the sample to produce a molten sample; and (d) detecting nuclear spin transitions in the at least one spin half nucleus of the analyte in the frozen or molten sample. In certain embodiments, the polarizing agents can be peptide-based. In these embodiments, the polarizing agents can be readily prepared by solid-phase peptide synthesis.
Type:
Grant
Filed:
August 6, 2018
Date of Patent:
November 15, 2022
Assignee:
Ohio State Innovation Foundation
Inventors:
Daniel W. Conroy, Christopher P. Jaroniec
Abstract: Estimation algorithms, methods, and systems are provided that estimate the internal temperatures inside of a part being built using powder bed fusion (PBF). Closed-loop state estimation is applied to the problem of monitoring temperature fields within parts during the PBF build process. A simplified linear time-invariant (LTI) model of PBF thermal physics with the properties of stability, controllability and observability is presented. In some aspects, an Ensemble Kalman Filter is applied to the model. Linear time-varying (LTV) systems are also contemplated.
Type:
Grant
Filed:
October 21, 2020
Date of Patent:
November 15, 2022
Assignee:
Ohio State Innovation Foundation
Inventors:
Nathaniel Joseph Wood, David John Hoelzle
Abstract: Infection with obligatory intracellular bacteria is difficult to treat as intracellular targets and delivery methods of therapeutics are not well-known. Ehrlichia translocated factor-1 (Etf-1), a type IV secretion system (T4SS) effector, is a primary virulence factor for an obligatory intracellular bacterium, Ehrlichia chaffeensis. Disclosed herein are Etf-1-specific nanobodies (Nbs) that block Etf-1 functions and Ehrlichia infection. Also disclosed is a method for treating human monocytic ehrlichiosis (HME) in a subject with the disclosed nanobodies.
Abstract: Disclosed herein are compounds, compositions, and methods for reactivating or realkylating aged acetylcholinesterase inhibited by or conjugated to the organophosphorus compound. The organophosphorus compound can be a nerve agent. The acetylcholinesterase can be in the central nerve system (CNS) and/or the peripheral nervous system (PNS) of a subject. Accordingly, methods for ameliorating, diminishing, reversing, treating or preventing the toxic effects of an organophosphorus compound in a subject are provided herein. Methods for prophylactic or therapeutic treatment of exposure to an organophosphorus nerve agent are also provided.
Type:
Grant
Filed:
February 15, 2018
Date of Patent:
November 8, 2022
Assignee:
OHIO STATE INNOVATION FOUNDATION
Inventors:
Christopher Hadad, Christopher Callam, Jeremy Beck, Qinggeng Zhuang, Andrew Franjesevic, Thomas Corrigan, Craig McElroy
Abstract: Devices for high throughput cell electroporation include a trapping component that at least partially defines an upper boundary of a microfluidic chamber. A cell trap array is patterned on the underside of the trapping component, and a channeling component is positioned beneath the trapping component. The channeling component includes a vertically oriented nanochannel array. The trapping component and the channeling component are positioned such that a given nanochannels is positioned beneath a cell trap. During use, fluid flow holds trapped cells in secure contact with the nanochannels beneath the cell trap. The device further includes upper and lower electrode layers for generating an electric field to electroporate trapped cells via the nanochannel array. A reservoir positioned beneath the channeling component can be filled transfection reagent solution. During electroporation, the transfection reagent solution travels through the nanochannel array during to transfect the trapped cells.
Abstract: Method and systems provide a tool to quantify sensory maps of the brain. Cortical surfaces are conformally mapped to a topological disk where local geometry structures are well preserved. Retinotopy data are smoothed on the disk domain to generate a curve that best fits the retinotopy data and eliminates noisy outliers. A Beltrami coefficient map is obtained, which provides an intrinsic conformality measure that is sensitive to local changes on the surface of interest. The Beltrami coefficient map represents a function where the input domain is locations in the visual field and the output is a complex distortion measure at these locations. This function is also invertible. Given the boundaries and the Beltrami map of a flattened cortical region, a corresponding visual field can be reconstructed. The Beltrami coefficient map allows visualization and comparison of retinotopic map properties across subjects in the common visual field space.
Type:
Grant
Filed:
December 21, 2018
Date of Patent:
November 8, 2022
Assignees:
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, OHIO STATE INNOVATION FOUNDATION
Abstract: The present application relates to nanoparticles for the targeted delivery of CRISPR/Cas13 systems, and their therapeutic use to treat diseases and disorders such as prostate cancer and COVID-19.
Type:
Application
Filed:
July 13, 2020
Publication date:
November 3, 2022
Applicants:
DUKE UNIVERSITY, OHIO STATE INNOVATION FOUNDATION
Abstract: The present disclosure is directed to formulations and methods for treatment of disease such as chemoprevention of cancer, for example oral squamous cell carcinoma (OSCC), and for methods of preparing the formulations. Further, the disclosure relates to local administration in slow release dosage forms for treatment of disease. The extended-release formulations are comprised of biodegradable polymeric implants (for example millicylinders and microspheres as well as in situ forming gels) and therapeutic agents selected from an anti-interleukin 6 agent, a synthetic vitamin A analogue and/or metabolite, and/or an estradiol metabolite for the local delivery of therapeutic agents to a site where a cancer has been previously excised or to prevent progression of a precancerous lesion.
Type:
Grant
Filed:
February 22, 2017
Date of Patent:
November 1, 2022
Assignees:
OHIO STATE INNOVATION FOUNDATION, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Inventors:
Susan Regina Mallery, Steven Paul Schwendeman
Abstract: Disclosed herein are methods of treating a subject with a bacterial infection, or preventing a bacterial infection, comprising administering to the subject an effective amount of at least one compound, or a derivative thereof, having the formula of SM1, SM3, SM4, or SM5. Also described are methods of inhibiting bacterial growth in a plant comprising contacting the plant with an effective amount of at least one compound, or a derivative thereof, having the formula of SM1, SM3, SM4, or SM5. The methods are effective against an array of bacterial pathogens in various animals and plants.
Type:
Grant
Filed:
December 20, 2018
Date of Patent:
October 25, 2022
Assignee:
Ohio State Innovation Foundation
Inventors:
Gireesh Rajashekara, Loic Deblais, Yosra A. Helmy, Dipak Kathayat, Sally A. Miller
Abstract: Systems and methods are provided for Integrated Circuit (IC) identification, authentication, and tamper detection. Die identification, authentication, and tamper detection techniques are described that employ capacitive sensing of on-chip interconnect. The signal and power routing in ICs have nominal capacitance values that are characteristic of their foundry, and the variance of these values, due to process tolerances, is unique to each device. Measuring these capacitances provides not only support for determining the authenticity of the device and fabrication site, but also provides distinct identification of each part. By integrating Capacitance-to-Digital Converters (CDCs) with low power and area overhead, capacitance values from intrinsic functional nets can be reported, and the need for separate additive test circuitry can be avoided.